New Zealand has agreed to buy 1.5 million doses of the vaccine from pharmaceutical companies, with the vaccine likely to be delivered in the first quarter of next year.
According to a report by a foreign news agency, the New Zealand government has agreed to buy a vaccine from the American pharmaceutical company 'Pfizer' and the German company 'Biotech' under which 1.5 million kroner vaccine will be provided next year after final preparation of the vaccine. Will be available in the first quarter.
According to the report, New Zealand has not yet stated the financial terms of the agreement, the vaccine will be given to about 750,000 people after the acquisition.
In addition, New Zealand is signing contracts with other companies to acquire the vaccine, which will be announced soon. The Wellington government has a mission to procure about 5 million vaccines.
Announcements in this regard are possible next month. It should be noted that Pefers and the biotech company have a significant role to play in the development of chronovaccines around the world, and so far there have been successes in vaccine experiments.
